Dry eye syndrome is a disease caused by a reduced production of tears (hypolacrymia) or insufficient production of fat (dyslacrimia).

Both hypolacrymia and dyslacrymia are caused by obstruction or malfunction of the meibomian glands which, positioned in the eyelids, are responsible for the production of the lipid layer of tears.

There are 25 to 40 meibomian glands in the upper eyelid and 20 to 30 in the lower eyelid. Their function is to secrete oils which, spreading over the surface of the eye, help to prevent tears from evaporating too quickly.

• The solution is the pulsed light IRPL which acts on the causal and no longer symptomatic part of the dry eye.
• It works by conveying high-powered light pulses on the periorbital zones and on the cheekbones which is completely harmless to the eye. However, it is able to generate heat and heats the treated part.

• The treatment is completely painless and free of contraindications or risks for the eyeball.
• The patient is made to lie down. A cold gel is applied in the area around the eyes that are covered by plastic protective glasses. Any moles or skin spots are covered with a plaster and treatment is carried out for a total time of a few seconds per eye.
• Immediately after the session, the patient can resume the usual activities having only the foresight to avoid sun exposure in the first 24/36 hours following the pulsed light treatment.
• Therapy should be repeated after 14 days, 45 days and, if necessary, 75 days after the first session.

The 85% percent of patients treated with the innovative Intense Regulated Pulsed Light therapy declared a great benefit and the definitive resolution of the annoying and often debilitating problem of dry eye.